HBL - Hadasit Bio-Holdings Ltd (TASE: HDST-M)
Health Care · Biotechnology · IL
₪—
— today · — 1Y
HBL - Hadasit Bio-Holdings Ltd (TASE: HDST-M) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.14M.
trading between 0.30 and 0.85.
Tweenvest scores HBL - Hadasit Bio-Holdings Ltd across four factors: quality 29/100, value 55/100. Its strongest factor is value.
HDST-M price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.14M
- Revenue (TTM)
- $13.09K
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- -0.49
- 52-week high
- ₪0.85
- 52-week low
- ₪0.30
- Avg volume (3M)
- —
- Shares outstanding
- 11.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics, Inc.NasdaqCM: LABT | $2.21M | $0.85 | -8.75% |
| Oragenics, Inc.NYSEAM: OGEN | $2.20M | $0.46 | -5.04% |
| BioAtla, Inc.OTCPK: BCAB | $2.18M | $1.31 | -11.49% |
| AccuStem Sciences, Inc.OTCPK: ACUT | $2.17M | $0.14 | +12.50% |
| Nirman Agri Genetics LimitedNSEI: NIRMAN | $2.12M | Rs25.45 | -2.86% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $2.08M | $0.78 | -4.88% |
| Abpro Holdings, Inc.OTCPK: ABPO | $2.08M | $0.35 | -13.90% |
| Anatara Lifesciences LtdASX: ANR | $1.97M | AU$0.01 | -10.00% |
Figures last refreshed Oct 4, 2026.